+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Embedding Medium for Frozen Sections Market by Type (Agarose, Gelatin, Tissue-Tek O.C.T Compound), End User (Diagnostic Labs, Hospitals, Research Institutes), Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6149999
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Unveiling the Essential Role of Embedding Media in Frozen Section Preparation to Enhance Diagnostic Precision and Accelerate Research Across Laboratories

Frozen section analysis is an indispensable technique in both clinical diagnostics and biomedical research, allowing rapid tissue evaluation directly at the point of care. By embedding fresh tissue samples in a supportive matrix, laboratories can cryosection specimens with exceptional morphological preservation and cellular fidelity. As a result, clinicians receive timely information to guide intraoperative decisions, and researchers benefit from high-quality samples that maintain native biomolecular integrity.

In recent years, the landscape of embedding media has evolved significantly, driven by innovations in polymer chemistry, enhanced cryoprotection properties, and a focus on workflow efficiency. These developments have elevated the consistency and reliability of frozen sections, reducing processing times while safeguarding delicate tissue structures. Furthermore, integration with next-generation imaging platforms has amplified the analytical power of histopathology and molecular assays.

Given the critical nature of these media in supporting diagnostic accuracy and research breakthroughs, stakeholders must understand the fundamental characteristics, material compositions, and performance parameters that differentiate leading formulations. This introduction sets the stage for a comprehensive examination of the transformative forces, regulatory influences, and strategic considerations shaping embedding medium solutions today.

Exploring the Transformative Advances Driving the Evolution of Embedding Media Technologies in Cryosection Workflows and Laboratory Practices Worldwide

The embedding medium sector for frozen sections is undergoing a period of rapid transformation, fueled by breakthroughs in material science and laboratory automation. Novel formulations incorporating advanced cryoprotectants, thermally responsive polymers, and bioinert additives are elevating the thermal stability and sectioning consistency of delicate tissues, which in turn supports more nuanced histological and molecular analyses.

Simultaneously, the convergence of digital pathology and automated cryostat platforms has reshaped laboratory workflows, allowing high-throughput processing without sacrificing sample quality. These integrated systems streamline specimen handling, reduce manual intervention, and enable real-time performance monitoring. In parallel, sustainability considerations have prompted the development of biodegradable and low-toxicity embedding compounds, reflecting a broader industry shift toward greener practices.

Taken together, these advances are redefining expectations for embedding media performance. As laboratories seek solutions that balance precision, throughput, and environmental responsibility, suppliers are compelled to innovate across formulation science, instrumentation compatibility, and regulatory compliance frameworks.

Assessing the Cumulative Impact of 2025 United States Tariffs on Supply Chains, Cost Structures, and Availability of Embedding Media for Frozen Sections

The introduction of new tariffs on raw materials imported into the United States in 2025 has had a noticeable ripple effect on the supply chains supporting embedding media production. Many formulations rely on specialty polymers and cryoprotective agents sourced from overseas suppliers, and the additional duties have increased input costs, necessitating adjustments throughout the value chain.

As a consequence, some manufacturers have pivoted toward regional sourcing strategies, seeking alternative polymer providers in North America and Latin America to mitigate exposure to tariff fluctuations. While these efforts have helped stabilize supply, they have also prompted incremental shifts in material specifications and processing parameters to maintain sectioning performance. In certain cases, end users have observed changes in freeze-thaw dynamics and tissue adherence, underscoring the importance of rigorous quality validation protocols.

Looking ahead, stakeholders will need to adopt flexible procurement strategies and collaborate closely with suppliers to manage ongoing cost pressures. By proactively addressing tariff-driven impacts, the frozen section ecosystem can preserve operational continuity, uphold sample integrity, and control total cost of ownership.

Highlighting the Critical Segmentation Dimensions Illuminating Diverse Requirements and Performance Across Embedding Media Types, End Users, and Applications

Segmentation by type reveals distinct performance attributes among agarose, gelatin, and Tissue-Tek O.C.T Compound. Agarose formulations deliver exceptional structural support and minimal background interference in downstream assays, whereas gelatin variants provide superior tissue penetration and ease of embedding for delicate specimens. Tissue-Tek O.C.T Compound, recognized for its balanced viscosity and rapid solidification, remains a preferred choice in high-throughput clinical settings.

When considering end users, diagnostic laboratories emphasize consistency, lot-to-lot reproducibility, and adherence to validated protocols, while hospitals prioritize fast turnaround times and regulatory compliance in surgical pathology. Research institutes, by contrast, often demand customizable media compositions that facilitate advanced molecular and immunohistochemical investigations, tailoring formulations to specialized experimental requirements.

Application-driven segmentation highlights how cytogenetics workflows benefit from media that preserve chromosomal architecture, histopathology demands clear tissue morphology with minimal ice crystal artifacts, and molecular pathology relies on embedding compounds that maintain nucleic acid integrity. Understanding these layered segmentation insights enables suppliers and end users to align product development and procurement strategies with the nuanced demands of each use case.

Uncovering Regional Dynamics Shaping Adoption Patterns and Strategic Priorities for Embedding Media in Frozen Section Workflows Across Global Geographies

Within the Americas, the embedding medium landscape is characterized by robust diagnostic infrastructure, widespread adoption of advanced cryostats, and a strong emphasis on regulatory compliance. Leading academic and commercial laboratories in North America leverage cutting-edge formulations to support both routine pathology and translational research, while Latin American markets exhibit growing interest in cost-effective media solutions that uphold quality standards.

Europe, Middle East & Africa presents a mosaic of regulatory frameworks and laboratory capabilities. Western European institutions often drive innovation in sustainable and clinical-grade embedding compounds, incorporating eco-conscious materials without compromising performance. In contrast, emerging markets across the Middle East and Africa are gradually building capacity for in-house tissue processing, favoring versatile media that accommodate variable storage and shipping conditions.

Asia-Pacific has emerged as a vibrant growth region, propelled by government investments in healthcare infrastructure and a burgeoning biotechnology sector. Local manufacturers are increasingly tailoring embedding media to meet regional temperature and humidity challenges, while research hubs in East Asia pursue specialized formulations that support novel diagnostic modalities and high-resolution imaging.

Examining Leading Industry Players Driving Innovation, Collaboration, and Competitive Differentiation in the Embedding Media Market for Frozen Sections

Leading industry players are differentiating themselves through targeted innovation, strategic partnerships, and comprehensive service offerings. Some suppliers have established collaborative R&D initiatives with academic centers to co-develop next-generation media incorporating bioactive coatings and enhanced cryoprotection properties. Others have invested in dedicated customer training programs, ensuring laboratory personnel can fully leverage advanced cryostat automation and digital pathology integration.

Moreover, key companies are forging agreements with global distributors to optimize supply chain resilience and expedite access to critical reagents. These alliances often include quality assurance audits, regulatory support for local registrations, and expedited logistics solutions. In parallel, select manufacturers have pursued ISO accreditation and third-party validations to bolster confidence in product consistency and compliance with international standards.

By combining material science expertise with comprehensive support services, these leading organizations are setting new benchmarks for performance, reliability, and user engagement in the frozen section embedding media domain.

Delivering Strategic Recommendations to Enhance Product Innovation, Optimize Supply Resilience, and Strengthen Partnerships in Frozen Section Embedding Workflows

To maintain a leadership position in the frozen section embedding media segment, companies should prioritize continuous material innovation while staying attuned to evolving laboratory needs. Investing in research partnerships that explore advanced cryoprotectants, biodegradable polymers, and customizable formulations will help address the dual imperatives of performance and sustainability. Concurrently, establishing regional procurement networks can mitigate supply disruptions caused by tariff shifts or logistical bottlenecks.

It is also advisable to develop comprehensive educational offerings that equip end users with best practices for media handling, cryostat calibration, and downstream assay compatibility. By providing training modules, application notes, and virtual support, suppliers can accelerate adoption and reinforce product value. Equally important is the cultivation of strategic alliances with instrumentation vendors and pathology software providers, enabling seamless integration of embedding media with automated workflows and digital analysis platforms.

Ultimately, a holistic approach that balances R&D investment, supply chain agility, and customer-centric services will empower industry leaders to capture emerging opportunities, enhance user satisfaction, and drive sustainable growth in the frozen section embedding media landscape.

Outlining the Robust Research Framework and Methodological Approach Underpinning Comprehensive Analysis of Embedding Media Utilization in Frozen Sections

The research underpinning this analysis was conducted using a multi-faceted methodological framework designed to ensure depth, accuracy, and practical relevance. Primary qualitative insights were gathered through in-depth interviews with pathologists, laboratory managers, procurement specialists, and R&D scientists, providing nuanced perspectives on embedding medium selection, performance benchmarks, and workflow integration challenges.

Complementing this primary research, secondary data sources included peer-reviewed journal articles, industry bulletins, regulatory filings, and supplier product literature. This information was systematically triangulated to verify emerging trends and material innovations. Additionally, select use cases were evaluated through observational site visits and virtual demonstrations of cryostat systems, ensuring that performance claims were validated under real-world laboratory conditions.

Finally, all findings underwent rigorous internal peer review and editorial oversight, aligning the report’s conclusions with the latest technological developments and regulatory guidelines. This comprehensive methodology guarantees that stakeholders receive actionable intelligence grounded in empirical evidence and expert consensus.

Synthesizing Key Insights and Future Outlook for Embedding Media Technologies to Inform Decision-Making and Propel Advancements in Frozen Section Practices

This report has delineated the pivotal factors shaping the embedding medium ecosystem for frozen section analysis, tracing the evolution of formulation science, assessing the impacts of tariff-induced cost dynamics, and unveiling segmentation and regional nuances. By synthesizing insights across material types, end users, and application contexts, stakeholders can pinpoint the optimal strategies for enhancing diagnostic precision and research outcomes.

Looking forward, the trajectory of embedding media innovation is likely to center on biofunctionalized compounds, AI-enabled quality control, and sustainable manufacturing practices. As laboratories continue to embrace automation and digital pathology, the demand for highly consistent, easy-to-use media will intensify. At the same time, global supply chain resilience and regulatory harmonization will remain paramount considerations, driving partnerships that bridge geographies and expertise.

Armed with these insights, decision-makers are well positioned to navigate the complexities of procurement, R&D investment, and workflow optimization. By aligning material advancements with strategic objectives, the frozen section community can unlock new possibilities in patient care and scientific discovery.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • Agarose
    • Gelatin
    • Tissue-Tek O.C.T Compound
  • End User
    • Diagnostic Labs
    • Hospitals
    • Research Institutes
  • Application
    • Cytogenetics
    • Histopathology
    • Molecular Pathology
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Sakura Finetek U.S.A., Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Merck KGaA
  • Avantor, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of advanced cryoembedding media to improve frozen section diagnostic accuracy and section integrity
5.2. Rising adoption of non-toxic agarose-based embedding compounds for rapid frozen section processing in clinical settings
5.3. Development of biodegradable embedding mediums for frozen sections to address environmental and regulatory concerns
5.4. Introduction of automated cryoembedding workflows combining high-throughput embedding media with AI guided quality control and standardization
5.5. Growing demand for specialized embedding formulations optimized for immunofluorescence and multiplex staining in frozen tissue sections
5.6. Emergence of chitosan based embedding media enhancing frozen section adhesion and morphological preservation at ultralow temperatures
5.7. Collaboration between embedding medium manufacturers and cryostat producers to standardize media formulations and ensure cross platform compatibility
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Embedding Medium for Frozen Sections Market, by Type
8.1. Introduction
8.2. Agarose
8.3. Gelatin
8.4. Tissue-Tek O.C.T Compound
9. Embedding Medium for Frozen Sections Market, by End User
9.1. Introduction
9.2. Diagnostic Labs
9.3. Hospitals
9.4. Research Institutes
10. Embedding Medium for Frozen Sections Market, by Application
10.1. Introduction
10.2. Cytogenetics
10.3. Histopathology
10.4. Molecular Pathology
11. Americas Embedding Medium for Frozen Sections Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Embedding Medium for Frozen Sections Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Embedding Medium for Frozen Sections Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Sakura Finetek U.S.A., Inc.
14.3.2. Thermo Fisher Scientific, Inc.
14.3.3. Danaher Corporation
14.3.4. Merck KGaA
14.3.5. Avantor, Inc.
15. Research AI16. Research Statistics17. Research Contacts18. Research Articles19. Appendix
List of Figures
FIGURE 1. EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET: RESEARCHAI
FIGURE 22. EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET: RESEARCHSTATISTICS
FIGURE 23. EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET: RESEARCHCONTACTS
FIGURE 24. EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY AGAROSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY AGAROSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY GELATIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY GELATIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TISSUE-TEK O.C.T COMPOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TISSUE-TEK O.C.T COMPOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY CYTOGENETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY CYTOGENETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY MOLECULAR PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY MOLECULAR PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. AMERICAS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 34. AMERICAS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 35. AMERICAS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. AMERICAS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. AMERICAS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 38. AMERICAS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 39. AMERICAS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 40. AMERICAS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 41. UNITED STATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 42. UNITED STATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 43. UNITED STATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. UNITED STATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. UNITED STATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 46. UNITED STATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 47. UNITED STATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 48. UNITED STATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 49. CANADA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 50. CANADA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 51. CANADA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. CANADA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. CANADA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. CANADA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. MEXICO EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 56. MEXICO EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 57. MEXICO EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. MEXICO EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. MEXICO EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 60. MEXICO EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 61. BRAZIL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 62. BRAZIL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 63. BRAZIL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. BRAZIL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. BRAZIL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. BRAZIL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. ARGENTINA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 68. ARGENTINA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 69. ARGENTINA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. ARGENTINA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. ARGENTINA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 72. ARGENTINA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED KINGDOM EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 82. UNITED KINGDOM EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 83. UNITED KINGDOM EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. UNITED KINGDOM EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED KINGDOM EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. GERMANY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 88. GERMANY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 89. GERMANY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. GERMANY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. GERMANY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. GERMANY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. FRANCE EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 94. FRANCE EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 95. FRANCE EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. FRANCE EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. FRANCE EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. FRANCE EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. RUSSIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 100. RUSSIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 101. RUSSIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. RUSSIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. RUSSIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. RUSSIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. ITALY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 106. ITALY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 107. ITALY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. ITALY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. ITALY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. ITALY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. SPAIN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 112. SPAIN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 113. SPAIN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. SPAIN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. SPAIN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. SPAIN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. UNITED ARAB EMIRATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 118. UNITED ARAB EMIRATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 119. UNITED ARAB EMIRATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. UNITED ARAB EMIRATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. UNITED ARAB EMIRATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED ARAB EMIRATES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 124. SAUDI ARABIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. SAUDI ARABIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. SAUDI ARABIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 130. SOUTH AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. SOUTH AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. SOUTH AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. SOUTH AFRICA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. DENMARK EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 136. DENMARK EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 137. DENMARK EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. DENMARK EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. DENMARK EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. DENMARK EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. NETHERLANDS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 142. NETHERLANDS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 143. NETHERLANDS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. NETHERLANDS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. NETHERLANDS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. NETHERLANDS EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. QATAR EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 148. QATAR EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 149. QATAR EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. QATAR EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. QATAR EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. QATAR EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. FINLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 154. FINLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 155. FINLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. FINLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. FINLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. FINLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. SWEDEN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 160. SWEDEN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 161. SWEDEN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. SWEDEN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. SWEDEN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. SWEDEN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. NIGERIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 166. NIGERIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 167. NIGERIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. NIGERIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. NIGERIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. NIGERIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. EGYPT EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 172. EGYPT EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 173. EGYPT EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. EGYPT EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. EGYPT EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. EGYPT EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. TURKEY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 178. TURKEY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 179. TURKEY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. TURKEY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. TURKEY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. TURKEY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. ISRAEL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 184. ISRAEL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 185. ISRAEL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. ISRAEL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. ISRAEL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. ISRAEL EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. NORWAY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 190. NORWAY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 191. NORWAY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. NORWAY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. NORWAY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. NORWAY EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. POLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 196. POLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 197. POLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. POLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. POLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. POLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. SWITZERLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 202. SWITZERLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 203. SWITZERLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. SWITZERLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. SWITZERLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. SWITZERLAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 208. ASIA-PACIFIC EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. ASIA-PACIFIC EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. ASIA-PACIFIC EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 214. ASIA-PACIFIC EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 215. CHINA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 216. CHINA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 217. CHINA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. CHINA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. CHINA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. CHINA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. INDIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 222. INDIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 223. INDIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. INDIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. INDIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. INDIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. JAPAN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 228. JAPAN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 229. JAPAN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. JAPAN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. JAPAN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. JAPAN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. AUSTRALIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 234. AUSTRALIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 235. AUSTRALIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. AUSTRALIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. AUSTRALIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. AUSTRALIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. SOUTH KOREA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 240. SOUTH KOREA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 241. SOUTH KOREA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. SOUTH KOREA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. SOUTH KOREA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. SOUTH KOREA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. INDONESIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 246. INDONESIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 247. INDONESIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. INDONESIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. INDONESIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. INDONESIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. THAILAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 252. THAILAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 253. THAILAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. THAILAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. THAILAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. THAILAND EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. PHILIPPINES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 258. PHILIPPINES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 259. PHILIPPINES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. PHILIPPINES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. PHILIPPINES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. PHILIPPINES EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. MALAYSIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 264. MALAYSIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 265. MALAYSIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. MALAYSIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. MALAYSIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. MALAYSIA EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. SINGAPORE EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 270. SINGAPORE EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 271. SINGAPORE EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. SINGAPORE EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. SINGAPORE EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. SINGAPORE EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. VIETNAM EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 276. VIETNAM EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 277. VIETNAM EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. VIETNAM EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. VIETNAM EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. VIETNAM EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. TAIWAN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 282. TAIWAN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 283. TAIWAN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. TAIWAN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. TAIWAN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. TAIWAN EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 288. EMBEDDING MEDIUM FOR FROZEN SECTIONS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Embedding Medium for Frozen Sections Market report include:
  • Sakura Finetek U.S.A., Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Merck KGaA
  • Avantor, Inc.